Hillcrest Clinical Research is categorized under Commercial Medical Research in Simpsonville, SC and active since 2005.
Hillcrest Clinical Research was established in 2005, and today employs 1 to 4, earning Unknown per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 5419100 by the NAICS.
If you are seeking more information, feel free to contact Robert Broker, President at the company’s single location by writing to 717 Se Main St, Simpsonville, South Carolina SC 29681 or by phoning (864) 962-5146. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Hillcrest Clinical Research |
| Contact Person: | Robert Broker, President |
| Address: | 717 Se Main St, Simpsonville, South Carolina 29681 |
| Phone Number: | (864) 962-5146 |
| Annual Revenue (USD): | Unknown |
| Founded: | 2005 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 5419100 |
| Share This Business: |
Hillcrest Clinical Research was started in 2005 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 5419100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Robert Broker, President for inquiries that concern Hillcrest Clinical Research by calling the company number (864) 962-5146, as your correspondence is most welcome. Additionally, the physical location of the single location of Hillcrest Clinical Research can be found at the coordinates 34.72009,-82.25146 as well as the street address 717 Se Main St in Simpsonville, South Carolina 29681.
For its online presence, you may visit Hillcrest Clinical Research’s website at and engage with its social media outlets through on Twitter and on Facebook.